Search research articles
Contact Us
Filters
Showing results (151-160 of 304) with videos related to
Page
of 31
Sort By:
Cells
|
April 30, 2021
Protein Binding Partners of Dysregulated miRNAs in Parkinson's Disease Serum
Wolfgang P Ruf, Axel Freischmidt, Veselin Grozdanov, et al.
ISME Communications
|
February 2, 2022
Systematic characterization of human gut microbiome-secreted molecules by integrated multi-omics
Bianca De Saedeleer, Antoine Malabirade, Javier Ramiro-Garcia, et al.
BMJ Open
|
August 19, 2023
Protocol for a multicentre cross-sectional, longitudinal ambulatory clinical trial in rheumatoid arthritis and Parkinson's disease patients analysing the relation between the gut microbiome, fasting and immune status in Germany (ExpoBiome)
Bérénice Hansen, Cédric C Laczny, Velma T E Aho, et al.
Journal of Neuroinflammation
|
August 20, 2017
Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease
Lori N Eidson, George T Kannarkat, Christopher J Barnum, et al.
Cell Reports
|
November 14, 2019
Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson's Disease
Johannes Hertel, Amy C Harms, Almut Heinken, et al.
Scientific Reports
|
July 15, 2022
Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson's disease
Florian Lipsmeier, Kirsten I Taylor, Ronald B Postuma, et al.
EMBO Molecular Medicine
|
April 25, 2025
Alpha-synuclein misfolding as fluid biomarker for Parkinson's disease measured with the iRS platform
Martin Schuler, Grischa Gerwert, Marvin Mann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 22, 2016
Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases
Franc Llorens, Niels Kruse, Matthias Schmitz, et al.
Plos Genetics
|
November 14, 2014
Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation
Diana F Lázaro, Eva F Rodrigues, Ramona Langohr, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 8, 2023
Defining the Riddle in Order to Solve It: There Is More Than One "Parkinson's Disease"
Tiago F Outeiro, Roy N Alcalay, Angelo Antonini, et al.
Page
of 31
Search research articles
Search
Showing results (151-160 of 304) with videos related to
Sort By:
Page
of 31
Cells
|
April 30, 2021
Protein Binding Partners of Dysregulated miRNAs in Parkinson's Disease Serum
Wolfgang P Ruf, Axel Freischmidt, Veselin Grozdanov, et al.
ISME Communications
|
February 2, 2022
Systematic characterization of human gut microbiome-secreted molecules by integrated multi-omics
Bianca De Saedeleer, Antoine Malabirade, Javier Ramiro-Garcia, et al.
BMJ Open
|
August 19, 2023
Protocol for a multicentre cross-sectional, longitudinal ambulatory clinical trial in rheumatoid arthritis and Parkinson's disease patients analysing the relation between the gut microbiome, fasting and immune status in Germany (ExpoBiome)
Bérénice Hansen, Cédric C Laczny, Velma T E Aho, et al.
Journal of Neuroinflammation
|
August 20, 2017
Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease
Lori N Eidson, George T Kannarkat, Christopher J Barnum, et al.
Cell Reports
|
November 14, 2019
Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson's Disease
Johannes Hertel, Amy C Harms, Almut Heinken, et al.
Scientific Reports
|
July 15, 2022
Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson's disease
Florian Lipsmeier, Kirsten I Taylor, Ronald B Postuma, et al.
EMBO Molecular Medicine
|
April 25, 2025
Alpha-synuclein misfolding as fluid biomarker for Parkinson's disease measured with the iRS platform
Martin Schuler, Grischa Gerwert, Marvin Mann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 22, 2016
Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases
Franc Llorens, Niels Kruse, Matthias Schmitz, et al.
Plos Genetics
|
November 14, 2014
Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation
Diana F Lázaro, Eva F Rodrigues, Ramona Langohr, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 8, 2023
Defining the Riddle in Order to Solve It: There Is More Than One "Parkinson's Disease"
Tiago F Outeiro, Roy N Alcalay, Angelo Antonini, et al.
Page
of 31